Prior Authorizations: Where Are We and Where Can We Go? Observations from a working group of leaders in the oncology and payer space
Introduction Prior authorization of medical procedures, services, and medications have been a standard requirement for health care providers for decades. Rising health care costs, specifically the escalating cost of cancer drug therapies, have led to a renewed focus by payers, providers, and policy makers on prior authorization. Similarly, the challenges and frustrations of the